USF Health was among top U.S. medical centers to test new ALS treatment shown to significantly benefit patients
This week’s New England Journal of Medicine reported results of the pivotal CENTAUR clinical trial; the USF Health ALS Clinic was one of only two sites in Florida […]
Transplanted bone marrow-derived endothelial progenitor cells delay ALS disease progression
A new University of South Florida preclinical study finds that the regenerative cell therapy boosts motor nerve cell survival by repairing the blood-spinal cord barrier TAMPA, Fla. (April […]
Patients at center of 8th annual FARA-USF scientific symposium
Patients have always been the center of the yearly scientific symposium hosted by the Friedreich’s Ataxia Research Alliance (FARA) and the University of South Florida Ataxia Research Center. […]
USF Health and FARA to host patient-focused scientific symposium Sept. 15 [Video]
International experts from academia and industry will gather to discuss advances in Friedreich’s ataxia from the laboratory to the clinic. Tampa, FL (Sept. 12, 2016) — The University of […]
USF Health and FARA to host Sept. 17 scientific symposium
Pharma, biotech leaders will discuss several new clinical studies testing drugs and gene therapy for Friedreich’s ataxia Tampa, FL (Aug. 31, 2015) — The University of South Florida (USF) […]